SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-153455
Filing Date
2021-05-06
Accepted
2021-05-06 17:10:55
Documents
5
Period of Report
2021-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d116190d8k.htm 8-K 22341
2 EX-1.1 d116190dex11.htm EX-1.1 209938
3 EX-5.1 d116190dex51.htm EX-5.1 9009
4 GRAPHIC g116190g13o06.jpg GRAPHIC 1934
5 GRAPHIC g116190g75g76.jpg GRAPHIC 4401
  Complete submission text file 0001193125-21-153455.txt   251460
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 21898899
SIC: 2834 Pharmaceutical Preparations